Legal & General Group Plc Makes New Investment in Chemed Corporation $CHE

Key Points

• Legal & General Group Plc purchased 19,927 Chemed shares worth approximately $9.3 million in the second quarter, joining other institutions that increased their holdings. Institutional investors collectively own 95.85% of Chemed.
• Chemed exceeded quarterly expectations, reporting $6.06 in earnings per share versus the $5.60 consensus estimate and revenue of $673.25 million, up 8.8% year over year. The company issued fiscal 2026 EPS guidance of $25.00 to $25.75.
• Chemed raised its quarterly dividend to $0.70 from $0.60, implying an annualized yield of about 0.5%. Analysts maintain a consensus “Hold” rating with an average price target of $530.75, while insiders have sold shares in recent months.

Legal & General Group Plc purchased a new position in Chemed Corporation (NYSE:CHE - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 19,927 shares of the company's stock, valued at approximately $9,281,000. Legal & General Group Plc owned 0.15% of Chemed at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Geneos Wealth Management Inc. raised its holdings in Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock worth $61,000 after purchasing an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in Chemed by 67.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company's stock valued at $5,534,000 after purchasing an additional 4,560 shares in the last quarter. Marshall Wace LLP bought a new position in Chemed during the 2nd quarter valued at $579,000. Brown Advisory Inc. increased its position in shares of Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company's stock valued at $267,000 after purchasing an additional 148 shares during the period. Finally, Cerity Partners LLC increased its position in shares of Chemed by 237.7% during the 2nd quarter. Cerity Partners LLC now owns 4,451 shares of the company's stock valued at $2,165,000 after purchasing an additional 3,133 shares during the period. 95.85% of the stock is currently owned by institutional investors.

Chemed Price Performance

NYSE CHE opened at $515.96 on Wednesday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The business's fifty day moving average is $512.52 and its two-hundred day moving average is $450.53. The stock has a market capitalization of $6.74 billion, a P/E ratio of 25.91, a P/E/G ratio of 1.96 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping the consensus estimate of $5.60 by $0.46. The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company's revenue was up 8.8% compared to the same quarter last year. During the same period last year, the company posted $4.27 EPS. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts forecast that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a $0.70 dividend. This is a positive change from Chemed's previous quarterly dividend of $0.60. The ex-dividend date is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's dividend payout ratio is 14.06%.

Analyst Ratings Changes

Several analysts have recently weighed in on CHE shares. Royal Bank Of Canada upped their price objective on Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a report on Thursday, July 30th. Weiss Ratings raised Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. Wall Street Zen raised shares of Chemed from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 1st. Bank of America reissued a "neutral" rating on shares of Chemed in a report on Wednesday, July 29th. Finally, Oppenheimer raised their price objective on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $530.75.

Insider Buying and Selling

In related news, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares of the company's stock, valued at approximately $7,526,948.48. This trade represents a 6.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the business's stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total value of $101,080.00. Following the sale, the director owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 6,537 shares of company stock worth $3,406,014. Company insiders own 3.33% of the company's stock.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.